An early stage cancer diagnostic test that provides highly accurate results for cancer detection. The test represents a unique diagnostic approach developed by Glycanostics for identifying cancer at early stages. It is designed to assist in cancer diagnosis and monitoring.
Manufactured by
Glycanostics, s.r.o.
Bratislava, Slovakia
At Glycanostics, our aim is to develop, clinically validate register an affordable, non-invasive next-gen liquid biopsy prostate cancer diagnostic test with accuracy of up to 90%.
© 2026 Suplivia · Home · Browse Products